The hematological effects of folate analogs: Implications for using the dihydrofolate reductase gene for in vivo selection

Human Gene Therapy

Volumn 7, Issue 17, 1996, Pages 2069-2078

  Blau, C Anthony ^a   Neff, Tobias ^a   Papayannopoulou, Thalia ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; FLUOROURACIL; FOLIC ACID DERIVATIVE; METHOTREXATE; STEM CELL FACTOR; TRIMETREXATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD TOXICITY; BONE MARROW; CELL CULTURE; CELL KILLING; CLINICAL PROTOCOL; COLONY FORMING UNIT C; COLONY FORMING UNIT S; DRUG EFFECT; DRUG MECHANISM; DRUG TOXICITY; FEMUR; GENE THERAPY; GENE TRANSFER; GENETIC SELECTION; HEMATOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; SPLEEN; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0029800571     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.17-2069     Document Type: Article

References (35)

1. CHU, E., and ALLEGRA, C.J. (1996) Antifolates. In Cancer Chemotherapy and Biotherapy: Principles and Practice. B.A. Chabner and D.L. Longo (J.B. Lippincott, Philadelphia) pp. 109-148.
2. BANERJEE, D., SCHWEITZER, B.I., VOLKENANDT, M., LI, M.-X., WALTHAM, M., MINEISHI, S., ZHAO, S.-C., and BERTINO, J.R. (1994). Transfection with a cDNA encoding a Ser31 or Ser34 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance. Gene 139, 269-274.
3. BERARDI, A.C., WANG, A., LEVINE, J.D., LOPEZ, P., and SCADDEN, D.T. (1995). Functional isolation and characterization of human hematopoietic stem cells. Science 267, 104-108.
4. BODINE, D.M., SEIDEL, N.B., ZSEBO, K.M., and ORLIC, D. (1993). In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 82, 445-455.
5. BRENNER, M.K., CUNNINGHAM, J.M., SORRENTINO, B.P., and HESLOP, H.E. (1995). Gene transfer into human hematopoietic progenitor cells. Br. Med. Bull. 51, 167-191.
6. BROWN, C.H., and CARBONE, P.P. (1971). Effects of chemotherapeutic agents on normal mouse bone marrow grown in vitro. Cancer Res. 31, 185-190.
7. BRUCE, W.R., MEEKER, B.E., and VALERIOTE, F.A. (1966). Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J. Natl. Cancer Inst. 37, 233-245.
8. BRUCE, W.R., MEEKER, B.E., POWERS, W.E., and VALERIOTE, F.A. (1969). Comparison of the dose- and time-survival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin. J. Natl. Cancer Inst. 42, 1015-1025.
9. CASH, J.M., and KLIPPEL, J.H. (1994). Second-line drug therapy for rheumatoid arthritis. N. Engl. J. Med. 330, 1368-1375.
10. CHU, E., and ALLEGRA, C.J. (1996). Antifolates. In Cancer Chemotherapy and Biotherapy, 2nd ed. B.A. Chabner and D.L. Longo, eds. (Lippincott-Raven Publishers, Philadelphia), pp. 109-148.
11. COREY, C.A., DESILVA, A.D., HOLLAND, C.A., and WILLIAMS, D.A. (1990). Serial transplantation of methotrexate-resistant bone marrow: protection of murine recipients from drug toxicity by progeny of transduced stem cells. Blood 75, 337-343.
12. DANCEY, J.T., DEUBELBEISS, K.A., HARKER, L.A., and FINCH, C.A. (1976). Neutrophil kinetics in man. J. Clin. Invest. 58, 705-715.
13. + peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood 85, 566-574.
14. HANANIA, E.G., FU, S., RONINSON, I., ZU, Z., GOTTESMAN, M.M., and DEISSEROTH, A.B. (1995). Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit. Gene Ther. 2, 279-284.
15. HOCK, R.A., and MILLER, A.D. (1986). Retrovirus-mediated transfer and expression of drug resistance genes in human haematopoietic progenitor cells. Nature 320, 275-277.
16. JONES, R.J., WAGNER, J.E., CELANO, P., ZICHA, M.S., and SHARKIS, S.J. (1990). Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature 347, 188-189.
17. LI, M., HANTZOPOULOS, P.A., BANERJEE, D., ZHAO, S.C., SCHWEITZER, B.I., GILBOA, E., and BERTINO, J.R. (1992). Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors. Hum. Gene Ther. 3, 381-390.
18. LI, M.-X., BANERJEE, D., ZHAO, S.-C., SCHWEITZER, B.I., MINEISHI, S., GILBOA, E., and BERTINO, J.R. (1994). Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction. Blood 83, 3403-3408.
19. MILLARD, R.E., BLACKETT, N.M., and OKELL, S.F. (1973). A comparison of the effect of cytotoxic agents on agar colony forming cells, spleen colony forming cells, and the erythrocytic repopulating ability of mouse bone marrow. J. Cell. Physiol. 82, 309-318.
20. MILLER, A.D. (1992). Human gene therapy comes of age. Nature 357, 455-460.
21. MODER, K.G., TEFFERI, A., COHEN, M.D., MENKE, D.M., and LUTHRA, H.S. (1995). Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: A retrospective study. Am. J. Med. 99, 276-281.
22. MOLINEUX, G., MIGDALSKA, A., HALEY, J., EVANS, G.S., and DEXTER, T.M. (1994). Total marrow failure induced by pegylated stem-cell factor administered before 5-fluorouracil. Blood 83, 3491-3499.
23. NARAYANAN, R., JASTREBOFF, M.M., and BERTINO, J.R. (1986). Development of an amphotropic, high-titer retrovirus vector expressing the dihydrofolate reductase gene and conferring methotrexate resistance. Gene 48, 71-80.
24. PINEDO, H.M., CHABNER, B.A., ZAHARKO, D.S., and BULL, J.M. (1976). Evidence for early recruitment of granulocyte precursors during high-dose methotrexate infusions in mice. Blood 48, 301-307.
25. PINEDO, H.M., ZAHARKO, D.S., BULL, J., and CHABNER, B.A. (1977). The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion. Cancer Res. 37, 445-450.
26. PODDA, S., WARD, M., HIMELSTEIN, A., RICHARDSON, C., FLOR-WEISS, E., SMITH, L., GOTTESMAN, M., PASTAN, I., and BANK, A. (1992). Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Natl. Acad. Sci. USA 89, 9676-9680.
27. SIMONSEN, C.C., and LEVINSON, A.D. (1983). Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc. Natl. Acad. Sci. USA 80, 2495-2499.
28. SORRENTINO, B.P., BRANDT, S.J., BODINO, G., GOTTESMAN, M., PASTAN, I., CLINE, A., and NIENHUIS, A.W. (1992). Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257, 99-103.
29. SPENCER, H.T., SLEEP, E.H., REHG, I.E., BLAKLEY, R.L., and SORRENTINO, B.P. (1996). A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood 87, 2579-2587.
30. STEAD, R.B., KWOK, W.W., STORB, R., and MILLER, A.D. (1988). Canine model for gene therapy: inefficient gene expression in dogs reconstituted with autologous marrow infected with retroviral vectors. Blood 71, 742-747.
31. STROMHAUG, A., WARREN, D.J., and SLORDAL, L. (1995). Effect of methotrexate on murine bone marrow cells in vitro: Evidence of a reversible anti-proliferative action. Exp. Hematol. 23, 439-443.
32. STROMHAUG, A., SLORDAL, L., and WARREN, D.J. (1996). Differential effects of the antifolates methotrexate, aminopterin and trimetrexate on murine progenitor cells. Br. J. Hematol. 92, 514-520.
33. VOGLER, W.R., MINGIOLI, E.S., and GARWOOD, F.A. (1973). The effect of methotrexate on granulocytic stem cells and granulopoiesis. Cancer Res. 33, 1628-1633.
34. WILLIAMS, D.A., HSIEH, K., DESILVA, A., and MULLIGAN, R.C. (1987). Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. J. Exp. Med. 166, 210-218.
35. ZAHARKO, D.S., DEDRICH, R.L., and BISCHOFF, K.B. (1971). Methotrexate tissue distribution: prediction by a mathematical model. J. Natl. Cancer Inst. 46, 775-784.